What is Path-Away?

Western Medicine. It is a well-established and widely accepted fact that Western Medicine is structured around “Synthetic” or “Man-Made” drugs. Why? The simple answer is synthesized compounds can be patented and monetized, compounds naturally occurring in nature can be monetized but not typically patented unless an intermediary compound has been isolated and proven to have medical benefit. To claim a compound effective for a specific medical use requires years of studies, clinical trials, and anywhere between Fifty to Five Hundred Million Dollars to secure regulatory approvals. It’s interesting to note that during the 20 th century fully 1/3 of our drug armamentarium was derived from plants and patented as pharmaceuticals.

Synthetic Drugs. The false perception this synthetic drug approval process perpetuates is that most pathogens occur in nature dressed in armor and bulletproof vests and like special-forces soldiers are very hard to kill. The truth is once a pathogen like SARS-COV-2 infects a human it becomes more complicated to kill and that’s where synthetic drugs come into place. As recent events have also clearly demonstrated, an inherent flaw in the design of Western Medicine processes is that they are very slow and at best reactive when it comes to newly discovered pathogens.

As the recent SARS-COV-2 Pandemic and history has undeniably demonstrated, Synthetic Drugs simply cannot keep pace with the speed and stealth of certain pathogens. This is compounded by the regulatory maze and expense for approval (even the most promising of synthetic drug candidates) of synthetic drugs to combat pandemic level pathogens like SARS-COV-2. As of April 6,2020 we have all been advised a vaccination is “hopefully” some eighteen to twenty months away for SARS-COV-2. So, in a best case scenario the best we can hope for at this point is a synthetic solution in 18 – 20 months…or is it?

Pathogen Origination. Fortunately viral, bacterial, mold, or fungal pathogens originate ex-vivo (outside the human body) and disinfection solutions fall under the regulatory control of the EPA who often collaborate with the CDC in the case of pathogens that can impact human health on establishing disinfection evaluation and approval criteria. Most significantly, the EPA lists ALL major active agent in Path-Away as known to kill SARS-COV-2.

Path-Away and EPAs GRAS List. But wait, Path-Away is by EPA classification safe for humans (See EPA Generally Accepted As Safe List), has a 99.999% effective kill rate against pathogens (Including SARS-COV-2), and can be instantly deployed and serve as the Predator (with the same speed and stealth to KILL a Broad Spectrum) of both easy (Such as SARS-COV-2) and hard to kill pathogens on a 24/7 365 day/year basis.

Path-Away, The Solution. In nature, it is also a well-established and widely accepted fact that the tables can often be turned. So, when a predator becomes the prey as is the case in using Path-Away against SARS-COV-2 it means we have simply found the ability to keep pace and eliminate the pathogens before or at the human exposure pathways. In the case of SARS-COV-2, Path-Away (A Nontoxic, Non-GMO, Certified Organic, Non Mucous Membrane & Skin Irritant, and, BROAD SPECTRUM, Viral, Bacterial, Mold, and Fungal Eradication Solution) has been used in planes, hospitals, commercial & industrial buildings, and literally any enclosed spaced delivered via surface, airborne (diffused through the ventilation system) that with a Log 4 Efficacy (pathogen-cidal in less Than One Minute) KILLS these pathogens preventing both spread and infection among humans! Want proof? Please visit our “Lab Results Page”.

N-PE Pledge. At N-PE we are so confident of our Product we provide Pre-Installation or Treatment Sampling and Post-Installation Treatment and Sampling of the M3 System (patent pending) and Proprietary Solution to confirm for our clients the system is hard at work 24/7 protecting their buildings and people.

Path-Away Anti-Pathogenic Aerosol Solution®

For 40+ years and across more than 20 countries Dr. Martin has pursued organic solutions to modern and ancient pathogen related health complications. He has interacted with traditional as well as alternative medicine practitioners in the USA and across the global community. His single focus has been to use nature to produce a plant based phytoceutical with remedial properties to improve human health and wellness.

The Path-Away® line of products is the result of that global search. All products contain a proprietary ingredient formulated from our classified plant extract process. That proprietary product is Certified Organic Input and Certified Non-GMO. Scientifically developed in the USA, our products have not used animals during any portion of the research and development process. A key goal of Professor Martin was that these products would not only be effective but safe enough for his own children and grandchildren but also take environmental stewardship into account.

The basic product formulation is directed at the control and/or elimination of a broad spectrum of fungi, bacteria, yeasts and viruses in buildings. Due to groundbreaking technology the product has use across a wide spectrum of market segments. It has been used to increase crop yield, help raise bigger and more healthy poultry, decontaminate nearly every mode of transportation private and public and even protect textiles.

With Certified Organic Input and a listing as non-GMO/alcohol free, Path-Away Anti-Pathogenic Aerosol Solution® has easily been recognized as safe and has been approved and certified for use by numerous countries as well as USA-EPA (actually “exempt” from registration), USA-FDA (all ingredients USA-FDA approved).

We know of no other product available to the public that received an approval for use as safe, effective and non-toxic at concentrations ranging from a low of 3% all the way up to 100% concentrated solution. This was certified by New Zealand EPA.

Path-Away Anti-Pathogenic Aerosol Solution® has proven to be highly effective against most common as well as unusual pathogens including H1N1, Mycobacterium tuberculosis, MRSA, Clostridium difficile and more.

A Few Words About COVID-19 (SARS-CoV2)

Path-Away Anti-Pathogenic Aerosol Solution® was successfully tested against two separate and distinct species and genus of the Coronaviridae family:

  1. The Feline coronavirus sample causing illness in animals is: ATCC VR-1508 Feline Coronavirus, Strain Munich.
  2. The COVID-19 SARS CoV2 strain is a separate, individual genus and species tested because it has a high virulence factor.

Path-Away Anti-Pathogenic Aerosol Solution® tested in excess of a Log4 (99.99%) kill factor.

What Does The Future Hold

Global Infection Control Consultants LLC will continue to strive for excellence and innovation related to Infection Control and continue to build on our product line’s safety and efficacy in order to bring Human Health and Wellness solutions to mankind as well as food, crop and animal biosafety solutions by working with Strategic Partners in the Global Community.

View the Path-Away Presentation Here

Play Video

Shopping cart


No products in the cart.